11P Patritumab deruxtecan (HER3-DXd) in previously treated patients (pts) with advanced EGFR-mutated (EGFRm) NSCLC: Updated safety results from HERTHENA-Lung01 H. Hayashi, Y. Goto, H.A. Yu, P.A. Jänne,J.C-H. Yang, M. Reck, K. Yoh,S-H. Lee, L. Paz-Ares, B. Besse, P. Bironzo,D-W. Kim, Z. Piotrowska, M.L. Johnson, A. Sporchia, K.H. Sullivan, Q. Dong, P. Shrestha, J. Shah, E. FelipESMO Open(2024)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要